TRANSFORM II will be featured at TCT 2026 as a Late-Breaking Clinical Trial.
Presented by Prof. Bernardo Cortese, the study compares a sirolimus-coated balloon with a drug-eluting stent in native coronary vessels. CERC is proud to contribute to this international trial across 14 sites in Bangladesh, Malaysia, Brunei, Thailand and Poland, supporting key activities including...
